Losartan Potassium 100 mg recalled over manufacturing violations
- Recall date
- April 30, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Direct Rx recalls Losartan Potassium 100 mg, 30 Tabs bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 NDC 6…
- Recall number
- D-0018-2021
- FDA classification
- Class II
- Brand / firm
- Direct Rx
- Sold / distributed
- GA
Why it was recalled
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level per manufacturer
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Losartan Potassium 100 mg, 30 Tabs bottles, Rx only, Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 NDC 61919-952-30
Get recall alerts
Free email alert whenever Direct Rx has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Direct Rx